Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.PureTech Health is a clinical-stage biopharma company with a pipeline of medicines targeting serious diseases caused by dysfunctions in the nervous, gastrointestinal (GI), and immune systems. Products for nervous system include Akili treatment for paediatric ADHD, Akili screen/monitor for Alzheimer's disease, and Karuna KarXT for Schizophrenia. Products for GI system include Gelesis100 for obesity, Gelesis200 for obesity and diabetes, and Entrega for oral delivery. Products for immune system include Follica RAIN for androgenetic alopecia, resTORbio for immunosenescence and related disorders, Vedanta VE303 for C. difficile and Vedanta VE202 for inflammatory bowel disease.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.